Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services

December 11, 2020 updated by: BELIN Delphine, Central Hospital, Nancy, France

Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy

The first period of COVID 19 Lockdown Measures (From 18 March to 11 may 2020) change the French people way of life and their medicine knowledges. A study which evaluates the Nancy's Pediatric emergencies population utilization during this time could detect pathological changes. The medical impact of Home Confinement will show an increase (trauma, maltreatment) or decrease (virus disease) of several pathology. The study aims to help clinicians to the children care if another time of Home Confinement happened. The main objective is to evaluate the behavioural changes and the reason consultation in Nancy's Pediatric Emergencies from 18 March to 30 June 2020 comparate to the same time in 2019. We will continue the search after the end of Home Confinement until 30 June 2020 to evaluate what happened just after.

Study Overview

Study Type

Observational

Enrollment (Actual)

11000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lorraine
      • Vandœuvre-lès-Nancy, Lorraine, France, 54500
        • CHRU Nancy's Pediatric Emergencies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 17 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All children who came to the Nancy's Pediatric emergencies during the period of the 18 march to the 30 June 2019 and 2020

Description

Inclusion Criteria:

  • children who are cared during the study period to the Nancy's pediatric emergencies

Exclusion Criteria:

  • be more than 18 years old
  • Not being seen by a doctor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children who came to the Nancy's Pediatric emergencies during the study period in 2019
Children who came to the Nancy's Pediatric emergencies during the study period in 2020

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patient who came to Nancy's pediatric emergencies during the study period
Time Frame: from 18 March to 30 June 2019 and 2020
from 18 March to 30 June 2019 and 2020
Reason of consultation during the study period
Time Frame: from 18 March to 30 June 2019 and 2020
from 18 March to 30 June 2019 and 2020

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of children who was send by a General practician
Time Frame: from 18 March to 30 June 2019 and 2020
from 18 March to 30 June 2019 and 2020
Medical reason to be sending by a General practician
Time Frame: from 18 March to 30 June 2019 and 2020
from 18 March to 30 June 2019 and 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 18, 2020

Primary Completion (Actual)

March 18, 2020

Study Completion (Actual)

June 30, 2020

Study Registration Dates

First Submitted

December 11, 2020

First Submitted That Met QC Criteria

December 11, 2020

First Posted (Actual)

December 16, 2020

Study Record Updates

Last Update Posted (Actual)

December 16, 2020

Last Update Submitted That Met QC Criteria

December 11, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2020PI235

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Number of Patients During the Studying Period

Subscribe